Onkologi i Sverige Nr 4

WELCOME TO OUR WEBINAR

Real life experiences of CAR-T in aggressive B-cell lymphoma – new learnings

HE-SE-2500035 aug 2025

Webinar 17 September 2025 12.05 CET

Join our webinar on treatment of aggressive B-cell lymphoma. Leading experts will discuss clinical vs. real-world outcomes and share practical strategies to optimize efficacy and safety in your daily practice.

When: Wednesday 17 September 2025, 12.05–13.00 CET

SPEAKER Prof Björn Chapuy

MODERATOR Prof Karin Ekström-Smedby Department of hematology-oncology, Karolinska University Hospital Stockholm, Sweden

Where: Webinar, register via bit.ly/bms17sept or scan QR code below

Deputy Director, Lead Attending and Section Head Lymphoma, Charité, University Medical Center Berlin, Germany

Welcome to send your questions to the speaker already now: bjorn.grindebratt@bms.com

PROGRAMME 12.05 Welcome

Johanna Mantela , Disease Area Specialist, Bristol Myers Squibb

12.10 Introduction

SCAN AND SIGN UP:

This invitation has been sent to healthcare professionals within hematology and oncology copying the head of clinic and relevant drug formulary committees. Individual participants must obtain approval for participation from their healthcare unit manager. Bristol Myers Squibb will reimburse honoraria for speaker and moderator. Prof Karin Ekström-Smedby , Department of hematology-oncology, Karolinska University Hospital Stockholm, Sweden 12.15 Real life experiences of CAR-T in aggressive B-cell lymphoma – new learnings Prof Björn Chapuy , Deputy Director, Lead Attending and Section Head Lymphoma, Charité, University Medical Center Berlin, Germany 12.45 Q&A Prof Karin Ekström-Smedby , Department of hematology-oncology, Karolinska University Hospital Stockholm, Sweden Prof Björn Chapuy , Deputy Director, Lead Attending and Section Head Lymphoma, Charité, University Medical Center Berlin, Germany 12.55 Closing All